Carl Daintree

Carl has deep cross-functional experience, across medical device, pharmaceuticals and Biotech, from start-up to large corporate. With a wealth of senior leadership and hands-on experience of taking an idea from the lab into clinical trials and on to commercialisation on tight budgets and short deadlines. In his last major role, COO at 30 Technology, Carl took a platform of products from prototype to a significant exit, initiating 8 clinical studies, building supply chain for a complex Class III medical device and a pharmaceutical for inhalation and building comprehensive go to market plans, all done in typical start-up fashion, with oversight and fully hands-on.